Federal Register / Vol. 87, No. 16 / Tuesday, January 25, 2022 / Notices 3851 

Dated: January 11, 2022. 

For the Nuclear Regulatory Commission. 

Bo M. Pham, 

Director, Division of Operating Reactor 

Licensing, Office of Nuclear Reactor 

Regulation. 

[FR Doc. 2022–00765 Filed 1–24–22; 8:45 am] 

BILLING CODE 7590–01–P 

NUCLEAR REGULATORY 

COMMISSION 

[Docket Nos. 50–341, 50–250, and 50–251; 

NRC–2020–0110] 

Issuance of Multiple Exemptions in 

Response to COVID–19 Public Health 

Emergency 

AGENCY: Nuclear Regulatory 

Commission. 

ACTION: Exemptions; issuance. 

SUMMARY: The U.S. Nuclear Regulatory 

Commission (NRC) issued two 

exemptions in response to requests from 

two licensees for relief due to the 

coronavirus 2019 disease (COVID–19) 

public health emergency (PHE). The 

exemptions afford these licensees 

temporary relief from certain 

requirements under NRC regulations. 

The NRC is issuing a single notice to 

announce the issuance of the 

exemptions. 

DATES: During the period from 

December 9, 2021, to December 30, 

2021, the NRC granted two exemptions 

in response to requests submitted by 

two licensees from December 6, 2021, to 

December 30, 2021. 

ADDRESSES: Please refer to Docket ID 

NRC–2020–0110 when contacting the 

NRC about the availability of 

information regarding this document. 

You may obtain publicly available 

information related to this document 

using any of the following methods: 

• Federal Rulemaking Website: Go to 

https://www.regulations.gov and search 

for Docket ID NRC–2020–0110. Address 

questions about Docket IDs in 

Regulations.gov to Stacy Schumann; 

telephone: 301–415–0624; email: 

Stacy.Schumann@nrc.gov. For technical 

questions, contact the individual listed 

in the FOR FURTHER INFORMATION

CONTACT section of this document. 

• NRC’s Agencywide Documents 

Access and Management System 

(ADAMS): You may obtain publicly 

available documents online in the 

ADAMS Public Documents collection at 

https://www.nrc.gov/reading-rm/ 

adams.html. To begin the search, select 

‘‘Begin Web-based ADAMS Search.’’ For 

problems with ADAMS, please contact 

the NRC’s Public Document Room (PDR) 

reference staff at 1–800–397–4209, 301– 

415–4737, or by email to 

PDR.Resource@nrc.gov. For the 

convenience of the reader, instructions 

about obtaining materials referenced in 

this document are provided in the 

‘‘Availability of Documents’’ section. 

• NRC’s PDR: You may examine and 

purchase copies of public documents, 

by appointment, at the NRC’s PDR, 

Room P1 B35, One White Flint North, 

11555 Rockville Pike, Rockville, 

Maryland 20852. To make an 

appointment to visit the PDR, please 

send an email to PDR.Resource@nrc.gov 

or call 1–800–397–4209 or 301–415– 

4737, between 8:00 a.m. and 4:00 p.m. 

(ET), Monday through Friday, except 

Federal holidays. 

FOR FURTHER INFORMATION CONTACT: 

James Danna, Office of Nuclear Reactor 

Regulation, U.S. Nuclear Regulatory 

Commission, Washington, DC 20555– 

0001; telephone: 301–415–7422, email: 

James.Danna@nc.gov. 

SUPPLEMENTARY INFORMATION: 

I. Introduction 

During the period from December 9, 

2021, to December 30, 2021, the NRC 

granted two exemptions in response to 

requests submitted by two licensees 

from December 6, 2021, to December 30, 

2021. These exemptions temporarily 

allow the licensees to deviate from 

certain requirements of chapter 1 of title 

10 of the Code of Federal Regulations 

(10 CFR), part 26, ‘‘Fitness for Duty 

Programs,’’ section 26.205, ‘‘Work 

hours.’’ 

The exemptions from certain 

requirements of 10 CFR part 26 for DTE 

Electric Company (for Fermi, Unit 2), 

and Florida Power & Light Company (for 

Turkey Point Nuclear Generating, Units 

3 and 4) afford these licensees 

temporary relief from the work-hour 

control requirements under 10 CFR 

26.205(d)(1) through (d)(7). The 

exemptions from 10 CFR 26.205(d)(1) 

through (d)(7) ensure that the control of 

work hours and management of worker 

fatigue does not unduly limit licensee 

flexibility in using personnel resources 

to most effectively manage the impacts 

of the COVID–19 PHE on maintaining 

the safe operation of these facilities. 

Specifically, these licensees have stated 

that their staffing levels are affected or 

are expected to be affected by the 

COVID–19 PHE, and they can no longer 

meet or likely will not meet the workhour controls of 10 CFR 26.205(d)(1) 

through (d)(7). These licensees have 

committed to effecting site-specific 

administrative controls for COVID–19 

PHE fatigue-management for personnel 

specified in 10 CFR 26.4(a). 

The tables in this notice provide 

transparency regarding the number and 

type of exemptions the NRC has issued. 

Additionally, the NRC publishes tables 

of approved regulatory actions related to 

the COVID–19 PHE on its public 

website at https://www.nrc.gov/aboutnrc/covid-19/reactors/licensingactions.html. 

II. Availability of Documents 

The tables in this notice provide the 

facility name, docket number, document 

description, and ADAMS accession 

number for each exemption issued. 

Additional details on each exemption 

issued, including the exemption request 

submitted by the respective licensee and 

the NRC’s decision, are provided in 

each exemption approval listed in the 

tables in this notice. For additional 

directions on accessing information in 

ADAMS, see the ADDRESSES section of 

this document. 

FERMI, UNIT 2—DOCKET NO. 50–341 

Document description ADAMS accession No. 

Fermi, Unit 2—Work Hour Limits Exemption Request due to COVID–19, dated December 6, 2021 ............................... ML21340A030 

Fermi, Unit 2—Exemption from Specific Requirements of 10 CFR part 26 (EPID L–2020–LLE–0053 [COVID–19]), 

dated December 9, 2021 ................................................................................................................................................. ML21340A245 

TURKEY POINT NUCLEAR PLANT, UNITS 3 AND 4—DOCKET NOS. 50–250 AND 50–251 

Document description ADAMS accession No. 

Turkey Point Nuclear Plant, Units 3 and 4—COVID–19 Related Request for Exemption from part 26 Work Hours Requirements, dated December 30, 2021 ........................................................................................................................... ML21364A050 


khammond on DSKJM1Z7X2PROD with NOTICES
3852 Federal Register / Vol. 87, No. 16 / Tuesday, January 25, 2022 / Notices 

1 ‘‘Regulated Funds’’ means the Existing 

Regulated Fund, the Future Regulated Funds and 

the BDC Downstream Funds (defined below). 

‘‘Future Regulated Fund’’ means a closed-end 

management investment company (a) that is 

registered under the Act or has elected to be 

regulated as a BDC, (b) whose investment adviser 

(and sub-adviser(s), if any) are an Adviser, and (c) 

that intends to participate in the Co-investment 

Program. ‘‘Adviser’’ means MSD and any Future 

Adviser. ‘‘Future Adviser’’ means any future 

investment adviser that (i) controls, is controlled 

by, or is under common control with MSD, (ii) (a) 

is registered as an investment adviser under the 

Investment Advisers Act of 1940 (‘‘Advisers Act’’) 

or (b) is a relying adviser of an investment adviser 

that is registered under the Advisers Act, and that 

controls, is controlled by, or is under common 

control with, MSD, and (iii) is not a Regulated Fund 

or a subsidiary of a Regulated Fund. 

2 ‘‘Affiliated Fund’’ means any Existing Affiliated 

Fund, any MSD Proprietary Account (as defined 

below) and any entity (a) whose investment adviser 

(and sub-adviser(s), if any) are Advisers, (b) that 

either (i) would be an investment company but for 

section 3(c)(1), 3(c)(5)(C) or 3(c)(7) of the Act or (ii) 

relies on rule 3a–7 under the Act, (c) that is not a 

BDC Downstream Fund, and (d) that intends to 

participate in the Co-Investment Program. ‘‘BDC 

Downstream Fund’’ means, with respect to any 

Regulated Fund that is a business development 

company (‘‘BDC’’), an entity (i) that the BDC 

directly or indirectly controls, (ii) that is not 

controlled by any person other than the BDC 

(except a person that indirectly controls the entity 

solely because it controls the BDC), (iii) that would 

be an investment company but for section 3(c)(1) or 

3(c)(7) of the Act, (iv) whose investment adviser 

(and sub-adviser(s), if any) are an Adviser, (v) that 

is not a Wholly-Owned Investment Sub and (vi) that 

intends to participate in the Co-Investment Program 

(defined below). 

TURKEY POINT NUCLEAR PLANT, UNITS 3 AND 4—DOCKET NOS. 50–250 AND 50–251—Continued 

Document description ADAMS accession No. 

Turkey Point Nuclear Plant Units 3 and 4—Exemption from Specific Requirements of 10 CFR part 26, ‘‘Fitness for 

Duty Programs’’ (EPID L–2021–LLE–0058 [COVID–19]), dated December 30, 2021 ................................................... ML21364A052 

Dated: January 20, 2022. 

For the Nuclear Regulatory Commission. 

James G. Danna, 

Chief, Plant Licensing Branch I, Division of 

Operating Reactor Licensing, Office of 

Nuclear Reactor Regulation. 

[FR Doc. 2022–01373 Filed 1–24–22; 8:45 am] 

BILLING CODE 7590–01–P 

SECURITIES AND EXCHANGE 

COMMISSION 

[Investment Company Act Release No. 

34477; File No. 812–15215] 

MSD Investment, LLC, et al. 

January 19, 2022. 

AGENCY: Securities and Exchange 

Commission (‘‘Commission’’). 

ACTION: Notice. 

Notice of application for an order 

under sections 17(d) and 57(i) of the 

Investment Company Act of 1940 (the 

‘‘Act’’) and rule 17d–1 under the Act to 

permit certain joint transactions 

otherwise prohibited by sections 17(d) 

and 57(a)(4) of the Act and rule 17d–1 

under the Act. 

SUMMARY OF APPLICATION: Applicants 

request an order to permit certain 

business development companies 

(‘‘BDCs’’) and closed-end management 

investment companies to co-invest in 

portfolio companies with each other and 

with certain affiliated investment funds 

and accounts. 

APPLICANTS: MSD Investment, Corp., 

(‘‘Existing Regulated Fund’’), MSD 

Partners, L.P. (‘‘MSD’’), MSD Credit 

Opportunity Master Fund, L.P., MSD 

Credit Opportunity Master Fund II, L.P., 

MSD Credit Opportunity Fund, L.P., 

MSD Credit Opportunity Fund 

(Cayman), L.P., MSD Credit Opportunity 

Fund, Ltd., MSD Debt REIT Holdings, 

L.P., MSDC EIV, LLC, MSD EIV Private, 

LLC, MSD RCOF TRS, LLC, MSD RCOF 

TRS (Cayman) LTD., MSD Real Estate 

Credit Opportunity Fund L.P., MSD 

Real Estate Credit Opportunity Fund-C 

L.P., RCOF-C Intermediate (Cayman), 

L.P, RCOF-C Intermediate, L.P., MSD 

Special Investments Fund, L.P., MSD 

SIF Holdings, L.P., MSD Special 

Investments Fund (Cayman), L.P., MSD 

SIF (Cayman), L.P., MSD Alpine Credit 

Opportunity Fund, L.P., MSD SBAFLA 

Fund, L.P., MSD UK Holdings Limited, 

MSD UK Holdings Ltd, MSD UK 

Aggregator Fund, LLC, MSD PCOF SMA 

1, LLC, MSD PCOF SMA 2, LLC, MSD 

RCOF SMA 1, LLC, MSD RCOF SMA 2, 

LLC, MSD, Private Credit Opportunity 

Master (ECI) Fund 2, L.P., MSD Private 

Credit Opportunity Master Fund 2, L.P., 

MSD Private Credit Opportunity Fund 

2, L.P., MSD Private Credit Opportunity 

Fund (Cayman) 2, L.P., MSD Private 

Credit Opportunity Fund (Cayman) II, 

L.P., Intermediate Fund PCOF 2, LLC, 

MSD PCOF Fund 2, Ltd, Onshore 

Intermediate Fund PCOF 2, LLC, MSD 

Onshore PCOF Fund 2, Ltd, MSD 

Private Credit Opportunity Master (ECI) 

Fund, L.P., MSD Private Credit 

Opportunity Master (ECI) Fund II, L.P., 

MSD Private Credit Opportunity Master 

Fund, L.P., MSD Private Credit 

Opportunity Fund, L.P., MSD Private 

Credit Opportunity Fund (Cayman), 

L.P., and MSD Private Credit 

Opportunity Fund II, L.P. (collectively, 

‘‘Existing Affiliated Funds’’). 

FILING DATES: The application was filed 

on April 1, 2021, and amended on 

November 18, 2021 and on January 18, 

2022. 

HEARING OR NOTIFICATION OF HEARING: 

An order granting the requested relief 

will be issued unless the Commission 

orders a hearing. Interested persons may 

request a hearing by emailing the 

Commission’s Secretary at SecretarysOffice@sec.gov and serving applicants 

with a copy of the request by email. 

Hearing requests should be received by 

the Commission by 5:30 p.m. on 

February 10, 2022, and should be 

accompanied by proof of service on the 

applicants, in the form of an affidavit, 

or, for lawyers, a certificate of service. 

Pursuant to rule 0–5 under the Act, 

hearing requests should state the nature 

of the writer’s interest, any facts bearing 

upon the desirability of a hearing on the 

matter, the reason for the request, and 

the issues contested. Persons who wish 

to be notified of a hearing may request 

notification by emailing the 

Commission’s Secretary at SecretarysOffice@sec.gov. 

ADDRESSES: The Commission: 

Secretarys-Office@sec.gov. Applicants: 

Robert Simonds, MSD Partners, L.P., 

rsimonds@msd.com. 

FOR FURTHER INFORMATION CONTACT: 

Harry Eisenstein, Senior Special 

Counsel, at (202) 551–6764 or Kaitlin C. 

Bottock, Branch Chief, at (202) 551– 

6825 (Division of Investment 

Management, Chief Counsel’s Office). 

SUPPLEMENTARY INFORMATION: The 

following is a summary of the 

application. The complete application 

may be obtained via the Commission’s 

website by searching for the file 

number, or for an applicant using the 

Company name box, at http://

www.sec.gov/search/search.htm or by 

calling (202) 551–8090. 

Introduction 

1. The applicants request an order of 

the Commission under sections 17(d) 

and 57(i) and rule 17d–1 thereunder 

(the ‘‘Order’’) to permit, subject to the 

terms and conditions set forth in the 

application (the ‘‘Conditions’’), a 

Regulated Fund 1 and one or more other 

Regulated Funds and/or one or more 

Affiliated Funds 2 to enter into CoInvestment Transactions with each 

other. ‘‘Co-Investment Transaction’’ 

means any transaction in which a 


khammond on DSKJM1Z7X2PROD with NOTICES